TABLE 1.
Para‐clinical work‐up for our patient who presented with mononeuropathy multiplex.
| Para‐clinical assessment | Normal range | |
|---|---|---|
| Hematologic | ||
| CBC | ||
| Hb | 9.9 | M: 14–18 |
| F: 12–16 | ||
| WBC | 4.6 | 4–10 |
| Plt | 236,000 | 140–440 |
| MCV | 69.4 | 77–97 |
| RDW | 21 | 11.8–14.5% |
| Retic count | 2.8% | 0.5–2.5% |
| Serum iron | 10 | 65–175 |
| Ferritin | 600 | 30–300 |
| Transferrin | 170 | 200–360 |
| ESR | 45 | 0–22 |
| Serum electrophoresis | Monoclonal IgA negative | |
| Urine electrophoresis | Monoclonal IgA negative | |
| Rheumatologic and vasculitis | ||
| ANA | Normal | |
| Anti‐Ro | Normal | |
| Anti‐La | Normal | |
| RF | Normal | |
| C3 | Normal | |
| C4 | Normal | |
| p‐ANCA | Normal | |
| c‐ANCA | Normal | |
| Paraneoplastic | ||
| CA19‐9 | Negative | |
| CA15‐3 | Negative | |
| CEA | Negative | |
| PSA | Negative | |
| AFP | Negative | |
| βHCG | Negative | |
| Infectious | ||
| HCV Ab | Negative | |
| HIV | Negative | |
| Viral markers | Negative | |
| VDRL | Negative | |
| PPD | Negative | |
| Toxins | ||
| Serum Pb | Normal | |
| Metabolic | ||
| HbA1C | Normal | |
| Neoplastic | ||
| Abdominopelvic CT | Splenomegaly | |
| Endoscopy and colonoscopy | No significant abnormalities | |
| Bronchoscopy | No malignant cell in biopsy | |
| Bone marrow aspiration and biopsy | Normocellular marrow with mild megaloid changes in erythroid series | |
Note: Cell counts were performed using the automated cell counter Sysmex® KP300. Biochemistry analyses were done using the Roche Hitachi 917 Rack Chemistry Analyzer, Japan; Serologic markers were checked using the ELISA kits from Autobio Diagnostics Co. and Liason Autobio A 2000 automated ELISA reader.
Abbreviations: AFP, alpha‐fetoprotein; ANA, antinuclear antibody; CBC, complete blood count; CEA, carcinoembryonic antigen; CT, computed tomography; ESR, erythrocyte sedimentation rate; HbA1C, glycated hemoglobin; HCV, hepatitis C virus; HIV, human immunodeficiency virus; p‐ANCA, perinuclear antineutrophil cytoplasmic antibodies; Pb, lead; PPD, purified protein derivative; PSA, prostate‐specific antigen; RF, rheumatoid factor; VDRL, venereal disease research laboratory (VDRL); βHCG, beta‐human chorionic gonadotropin.